Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06277310 · ClinicalTrials.gov registry record · NA

Wishes to Improve Support and Humanity at End-of-life in Safety-net Hospitals

A NA study of End of Life, sponsored by University of California, Los Angeles.

Active
Registry status
NA
Development phase
900
Enrollment target
4
Study locations

NCT06277310: Active NA study of End of Life, sponsored by University of California, Los Angeles.

NCT06277310 is a NA study of End of Life that is active but no longer recruiting, run by University of California, Los Angeles. The registered enrollment target is 900 participants, above the 690-participant average among 10 other End of Life trials with a reported enrollment target (30% higher). The trial reports 4 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06277310, a NA study of End of Life, is active but no longer recruiting, sponsored by University of California, Los Angeles.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
900 participants
Enrollment target
4
Study locations

Study Summary

Dignified and compassionate end-of-life (EOL) care is a cornerstone of high-quality, patient-centered care, but in safety-net hospitals EOL care is often overlooked, considered too late, or not at all. By eliciting and implementing final wishes for dying patients, the 3 Wishes Project (3WP) has demonstrated, in tertiary academic centers, that acts of compassion can improve the EOL experience and help families cope with loss. The investigators propose to implement the 3WP in safety-net hospitals where there are less resources and more diverse, disadvantaged patient populations, and hypothesize that there will be similar positive effects on the EOL experience for patients, families, and clinicians.

Primary Outcome

Bereaved families of patients who died in the ICU will complete an after-death survey, which includes the Bereaved Family Survey (BFS). The BFS asks questions regarding the family's perception of the patient's end of life care. We will also use a question from the FS-ICU (family satisfaction with ICU) to assess whether family felt supported in final hours of patient's life.

Conditions Studied

Interventions

  • OTHER 3 Wishes Project

Study Locations (4)

California

  • LA General Hospital - Los Angeles
  • Ronald Reagan UCLA Medical Center - Los Angeles
  • Olive View Medical Center - Sylmar
  • Harbor-UCLA - Torrance

Trial Details

FieldValue
Enrollment Target 900 participants
Start Date 2024-03-19
Est. Completion 2028-08
Phase NA

What the registry record for NCT06277310 still lists

NCT06277310 is an interventional study that assigns participants to a tested intervention. The registered 900 participants enrollment target is mid-sized for trials with a published cap, above the 690-participant average among 10 other End of Life trials with a reported enrollment target (30% higher).

The record links to 1 condition, with End of Life appearing as the primary indexed condition, and to 1 intervention - of which 3 Wishes Project is the first listed.

NCT06277310 reports a single indexed study location in California.

Frequently Asked Questions

What is clinical trial NCT06277310 about?

NCT06277310 is a clinical study titled "Wishes to Improve Support and Humanity at End-of-life in Safety-net Hospitals". Dignified and compassionate end-of-life (EOL) care is a cornerstone of high-quality, patient-centered care, but in safety-net hospitals EOL care is often overlooked, considered too late, or not at all. By eliciting and implementing final wishes for dying patients, the 3 Wishes Project (3WP) has demo...

What is the current status of trial NCT06277310?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 900 participants. The study started on 2024-03-19. Estimated completion is 2028-08.

What conditions does trial NCT06277310 study?

This clinical trial studies the following conditions: End of Life.

What interventions are being tested in trial NCT06277310?

The interventions under investigation include: 3 Wishes Project (OTHER).

Who is sponsoring clinical trial NCT06277310?

This trial is sponsored by University of California, Los Angeles, which has 897 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06277310 being conducted?

This trial has 4 study locations across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for End of Life

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT06277310's enrollment target sits among peer trials

900 3rd of 10 higher than 8 of 10 other End of Life trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other End of Life trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02352116 · 900 participants · NA

    Evaluation of Post-PACU Pain Management in Pediatric Surgery

  • NCT02414347 · 900 participants

    F 18 T807 Tau PET Imaging of Alzheimer's Disease

  • NCT02670408 · 900 participants

    Diagnostic and Therapeutic Applications of Microarrays in Heart Transplantation

  • NCT02960022 · 900 participants · Phase 2

    A Study for Subjects With Prostate Cancer Who Previously Participated in an Enzalutamide Clinical Study

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06277310, the US trial registry maintained by the National Library of Medicine. NCT06277310 (mid enrollment · single site footprint · active not recruiting) retrieved and formatted by PlainTrial, see methodology.